The layer-by-layer deposition strategy of additive manufacturing makes it ideal to fabricate dissimilar alloy components with varying functionality,which has promising application potential in a large number of indust...The layer-by-layer deposition strategy of additive manufacturing makes it ideal to fabricate dissimilar alloy components with varying functionality,which has promising application potential in a large number of industrial areas.In this study,two components composed of ERCuAl-A2 aluminum bronze(CuAl9)and Inconel 718 nickel-based superalloy were fabricated with different deposition orders by wire-arc directed energy deposition.Subject to changes in heat input and thermophysical properties of the substrate,the transition region of the deposited Cu-Ni component with the bottom half of CuAl9 and the top half of Inconel 718 is narrow and serrated.This region features a laminated intermetallic compound layer due to the convection and rapid cooling in the molten pool.In contrast,the Ni-Cu component deposited in the opposite order exhibits a 2 mm gradient transition zone.Within this region,a large number of diverse precipitates were found as well as regional variations in grain size due to the multi-layer partial remelting.Both two components show strong bonds and their tensile specimens tested along the vertical direction always fracture at the softer CuAl9 side.Excellent tensile properties along the horizontal direction were obtained for Cu-Ni(Ultimate tensile strength:573 MPa,yield stress:302 MPa,elongation:22%),while those of Ni-Cu are much lower due to the existence of the solidification cracks in the transition zone.The results from this study provide a reference for the additive manufacturing of Cu/Ni dissimilar alloy components,as well as their microstructure and mechanical properties control.展开更多
BACKGROUND Despite being the gold standard,the use of glycated hemoglobin(HbA1c)and fasting plasma glucose(FPG)for diagnosing dysglycemia is imperfect.In particular,a low level of agreement between HbA1c and FPG in de...BACKGROUND Despite being the gold standard,the use of glycated hemoglobin(HbA1c)and fasting plasma glucose(FPG)for diagnosing dysglycemia is imperfect.In particular,a low level of agreement between HbA1c and FPG in detecting prediabetes and diabetes has led to difficulties in clinical interpretation.Glycated albumin(GA)and 1,5-anhydroglucitol(1,5-AG)may potentially serve as biomarkers for the detection and prediction of diabetes,as well as glycemic monitoring.AIM To explore the diagnostic performance of GA and 1,5-AG for screening dysglycemia;assess whether they can be used for glycemic monitoring in Chinese morbidly-obese patients;and examine their predictive ability for incident diabetes in a Chinese community-based cohort.METHODS GA and 1,5-AG concentrations were measured in 462 morbidly-obese patients from the Obese Chinese Cohort(OCC).A sub-group of diabetes subjects(n=24)was prospectively followed-up after bariatric surgery.Differences between baseline and post-surgery biomarker values were converted to percentage change from baseline to assess the response to glycemic control.Predictive ability of the biomarkers was assessed in 132 incident diabetes cases and 132 matched non-diabetes controls in the community-based Cardiovascular Risk Factor Prevalence Study(CRISPS).A prediction model was developed and compared with clinical models based on conventional risk factors.RESULTS GA exhibited an excellent diagnostic value with an area under the receiver operating characteristic curve(AUC)of 0.919(95%CI:0.884-0.955)for identifying diabetes and a high agreement in the classification of diabetes with both FPG and HbA1c in the OCC.GA demonstrated the fastest response to glycemic control.In CRISPS,the‘B3A’prediction model,which consisted of body mass index(BMI)and 3 biomarkers(HbA1c,GA and 1,5-AG),achieved a comparable predictive value[AUC(95%CI):0.793(0.744-0.843)]to that of a clinical model comprising BMI,HbA1c,FPG and 2-hour glucose(2hG)[AUC(95%CI):0.783(0.733-0.834);DeLong P value=0.736].The‘B3A’was significantly superior to a clinical model including BMI,HbA1c,FPG and triglycerides[AUC(95%CI):0.729(0.673-0.784);DeLong P value=0.027].CONCLUSION GA and 1,5-AG have the potential to act as robust biomarkers for the screening and risk prediction of diabetes.FPG and 2hG may be replaced by GA and 1,5-AG in future diabetes predictions.展开更多
Polycystic ovary syndrome(PCOS)is a prevalent endocrine disorder that poses a significant threat to women’s health.As a classical traditional Chinese medicine(TCM)formulation,Guizhi-Fuling Wan(GFW)has a good applicat...Polycystic ovary syndrome(PCOS)is a prevalent endocrine disorder that poses a significant threat to women’s health.As a classical traditional Chinese medicine(TCM)formulation,Guizhi-Fuling Wan(GFW)has a good application prospect in the complementary treatment of PCOS.This study aimed to systematically summarize the traditional efficacy and pharmacological composition of the Chinese medicines contained in GFW and evaluate the clinical efficacy and safety of their active ingredients in the complementary treatment of PCOS.A growing number of studies have demonstrated that GFW is effective at complementally treating PCOS through various mechanisms,including inhibiting inflammatory responses,modulating the intraovarian extracellular matrix,regulating apoptosis and autophagy in granulosa cells,and correcting oxidative stress imbalances.In addition,the GFW has been shown to be effective in treating the complications of PCOS.However,there are several problems,and future work should focus on elucidating the efficacy,safe dosage,and safety of different dosage forms of GFW,increasing the toxicological value of traditional Chinese medicine,and confirming the safety of the combination of GFW with Western medicine for the treatment of PCOS.展开更多
基金supported by the Key Research and Development Program of Shaanxi Province(2023-YBGY361)the National Natural Science Foundation of China(52275374 and 52205414)+1 种基金the Postdoctoral Fellowship Program of CPSF(GZC20232098)as well as the Xiaomi Foundation through Xiaomi Young Scholar Program。
文摘The layer-by-layer deposition strategy of additive manufacturing makes it ideal to fabricate dissimilar alloy components with varying functionality,which has promising application potential in a large number of industrial areas.In this study,two components composed of ERCuAl-A2 aluminum bronze(CuAl9)and Inconel 718 nickel-based superalloy were fabricated with different deposition orders by wire-arc directed energy deposition.Subject to changes in heat input and thermophysical properties of the substrate,the transition region of the deposited Cu-Ni component with the bottom half of CuAl9 and the top half of Inconel 718 is narrow and serrated.This region features a laminated intermetallic compound layer due to the convection and rapid cooling in the molten pool.In contrast,the Ni-Cu component deposited in the opposite order exhibits a 2 mm gradient transition zone.Within this region,a large number of diverse precipitates were found as well as regional variations in grain size due to the multi-layer partial remelting.Both two components show strong bonds and their tensile specimens tested along the vertical direction always fracture at the softer CuAl9 side.Excellent tensile properties along the horizontal direction were obtained for Cu-Ni(Ultimate tensile strength:573 MPa,yield stress:302 MPa,elongation:22%),while those of Ni-Cu are much lower due to the existence of the solidification cracks in the transition zone.The results from this study provide a reference for the additive manufacturing of Cu/Ni dissimilar alloy components,as well as their microstructure and mechanical properties control.
基金Supported by the Hong Kong Research Grants Council Area of Excellence,No.AoE/M/707-18.
文摘BACKGROUND Despite being the gold standard,the use of glycated hemoglobin(HbA1c)and fasting plasma glucose(FPG)for diagnosing dysglycemia is imperfect.In particular,a low level of agreement between HbA1c and FPG in detecting prediabetes and diabetes has led to difficulties in clinical interpretation.Glycated albumin(GA)and 1,5-anhydroglucitol(1,5-AG)may potentially serve as biomarkers for the detection and prediction of diabetes,as well as glycemic monitoring.AIM To explore the diagnostic performance of GA and 1,5-AG for screening dysglycemia;assess whether they can be used for glycemic monitoring in Chinese morbidly-obese patients;and examine their predictive ability for incident diabetes in a Chinese community-based cohort.METHODS GA and 1,5-AG concentrations were measured in 462 morbidly-obese patients from the Obese Chinese Cohort(OCC).A sub-group of diabetes subjects(n=24)was prospectively followed-up after bariatric surgery.Differences between baseline and post-surgery biomarker values were converted to percentage change from baseline to assess the response to glycemic control.Predictive ability of the biomarkers was assessed in 132 incident diabetes cases and 132 matched non-diabetes controls in the community-based Cardiovascular Risk Factor Prevalence Study(CRISPS).A prediction model was developed and compared with clinical models based on conventional risk factors.RESULTS GA exhibited an excellent diagnostic value with an area under the receiver operating characteristic curve(AUC)of 0.919(95%CI:0.884-0.955)for identifying diabetes and a high agreement in the classification of diabetes with both FPG and HbA1c in the OCC.GA demonstrated the fastest response to glycemic control.In CRISPS,the‘B3A’prediction model,which consisted of body mass index(BMI)and 3 biomarkers(HbA1c,GA and 1,5-AG),achieved a comparable predictive value[AUC(95%CI):0.793(0.744-0.843)]to that of a clinical model comprising BMI,HbA1c,FPG and 2-hour glucose(2hG)[AUC(95%CI):0.783(0.733-0.834);DeLong P value=0.736].The‘B3A’was significantly superior to a clinical model including BMI,HbA1c,FPG and triglycerides[AUC(95%CI):0.729(0.673-0.784);DeLong P value=0.027].CONCLUSION GA and 1,5-AG have the potential to act as robust biomarkers for the screening and risk prediction of diabetes.FPG and 2hG may be replaced by GA and 1,5-AG in future diabetes predictions.
基金supported by funds from the Natural Science Foundation of Shandong Province(No.ZR2020MH346No.ZR2021MH003)the National Natural Science Foundation of China(No.81273667).
文摘Polycystic ovary syndrome(PCOS)is a prevalent endocrine disorder that poses a significant threat to women’s health.As a classical traditional Chinese medicine(TCM)formulation,Guizhi-Fuling Wan(GFW)has a good application prospect in the complementary treatment of PCOS.This study aimed to systematically summarize the traditional efficacy and pharmacological composition of the Chinese medicines contained in GFW and evaluate the clinical efficacy and safety of their active ingredients in the complementary treatment of PCOS.A growing number of studies have demonstrated that GFW is effective at complementally treating PCOS through various mechanisms,including inhibiting inflammatory responses,modulating the intraovarian extracellular matrix,regulating apoptosis and autophagy in granulosa cells,and correcting oxidative stress imbalances.In addition,the GFW has been shown to be effective in treating the complications of PCOS.However,there are several problems,and future work should focus on elucidating the efficacy,safe dosage,and safety of different dosage forms of GFW,increasing the toxicological value of traditional Chinese medicine,and confirming the safety of the combination of GFW with Western medicine for the treatment of PCOS.
